arrow
M

Mercedes Gori

cnr-ifc
H指数:13
被引数:683

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Treosulfan-based double-alkylator conditioning in myelofibrosis: An Italian retrospective multicenter analysis

曲奥舒凡为基础的双烷化剂预处理方案在骨髓纤维化中的应用:一项意大利多中心回顾性分析

2025-12-260
PRE
Efficacy of Polyvinylpyrrolidone–Zinc Gluconate and Taurine Gel in the Prophylaxis of Oral Mucositis in Adults Undergoing High-Dose Chemotherapy and Allogeneic Stem Cell Transplantation

聚乙烯吡咯烷酮-葡萄糖酸锌和牛磺酸凝胶在预防接受高剂量化疗和同种异体干细胞移植的成人口腔黏膜炎中的疗效

2025-12-190
OAAI
Possible correlation between Triglyceride/HDL ratio and subclinical myocardial damage in patients with cardiovascular risk factors

甘油三酯/高密度脂蛋白比值与心血管风险因素患者亚临床心肌损伤之间可能的关联

2025-08-280
OAAI
Osteopontin and Clinical Outcomes in Hemodialysis Patients
2024-11-141
OAAI
Plasma levels of myeloperoxidase and resistin independently predict mortality in dialysis patients
2024-11-010
PRE
Long-term cognitive function changes with non-vitamin K oral anticoagulants in older patients with atrial fibrillation. A multicenter cohort study
2024-09-230
PRE
Retrospective ANalysis of multi-drug resistant Gram-nEgative bacteRia on veno-venous extracorporeal membrane oxygenation. The multicenter RANGER STUDY
2024-08-270
OAAI
Proprotein convertase subtilisin/kexin type 9 (PCSK9) and clinical outcomes in dialysis patients

前蛋白转化酶枯草杆菌蛋白酶/kexin 9型 (PCSK9) 与透析患者的临床结局

2024-05-112
PRE
Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high-dose melphalan and autologous stem cell transplantation (vol 102, pg 1915, 2023)
2023-06-220
OAAI
Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high-dose melphalan and autologous stem cell transplantation

生物仿制药pegfilgrastim在大剂量马法兰和自体干细胞移植后的多发性骨髓瘤患者中的有效性

2023-04-203
OAAI
Mortality and prognostic factors in patients with bullous pemphigoid: a retrospective multicenter Italian study
2022-09-105
OA
Letermovir Prophylaxis for Cytomegalovirus Infection in Allogeneic Stem Cell Transplantation: A Real-World Experience
2021-09-0629
OAAI